Richard A. Heyman - Jun 5, 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Director
Signature
/s/ Robert Ticktin, by power of attorney
Stock symbol
PMVP
Transactions as of
Jun 5, 2025
Transactions value $
$0
Form type
4
Date filed
6/9/2025, 04:26 PM
Previous filing
Feb 10, 2025
Next filing
Oct 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Heyman Richard A. Director C/O PMV PHARMACEUTICALS, INC, 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON /s/ Robert Ticktin, by power of attorney 2025-06-09 0001584759

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Award $0 +33.5K $0.00 33.5K Jun 5, 2025 Common Stock 33.5K $0.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders.